A novel variant in STAT2 presenting with hemophagocytic lymphohistiocytosis - 05/08/19
Doi : 10.1016/j.jaci.2019.05.008
Mohammed F. Alosaimi, MD a, b, ∗, Michelle C. Maciag, MD a, ∗, Craig D. Platt, MD, PhD a, Raif S. Geha, MD a, Janet Chou, MD a, Lisa M. Bartnikas, MD a 
a Division of Immunology, Boston Children's Hospital and Harvard Medical School, Boston, Mass
b Department of Pediatrics, King Saud University, Riyadh, Saudi Arabia
| Supported by T32AI007512 (to M.C.M.), 1R01AI139633-01 (to R.S.G.), the Perkin Foundation (to R.S.G.), 5K08AI116979-04 (to J.C.), and K23AI143962-01 (to L.M.B.). |
|
| Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest. |
© 2019
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 144 - N° 2
P. 611 - août 2019 Retour au numéro
Article précédent
- Virus-specific T-cell clonotypes might contribute to drug hypersensitivity reactions through heterologous immunity
- Coral-Ann Almeida, Paula van Miert, Kane O'Driscoll, Yvonne M. Zoet, Abha Chopra, Campbell Witt, Mina John, Frans H.J. Claas, Lloyd J. D'Orsogna
- GATA-2–deficient mast cells limit IgE-mediated immediate hypersensitivity reactions in human subjects
- Avanti Desai, Kathryn Sowerwine, Yihui Liu, Monica G. Lawrence, Jack Chovanec, Amy P. Hsu, Michael P. O'Connell, Jiwon Kim, Lisa Boris, Nina Jones, Laura Wisch, Robin R. Eisch, Melody C. Carter, Hirsh D. Komarow, Christa Zerbe, Joshua D. Milner, Irina Maric, Xiaoping Sun, Chyi-Chia R. Lee, Ilker Tunc, Mehdi Pirooznia, Kelly D. Stone, Steven M. Holland, Dean D. Metcalfe, Jonathan J. Lyons
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?